Med24
Clinical Medicine 16. 10. 2026 • 2 min read • medical-news

First At-Home Thyroid Eye Disease Shot Approved

The FDA approved satralizumab (Enspryng), the first and only at-home subcutaneous treatment option for adults with thyroid eye disease (TED), developer Roche announced on Thursday. The first-in-class drug is a humanized monoclonal...

First At-Home Thyroid Eye Disease Shot Approved

The FDA has approved satralizumab, the first at-home subcutaneous treatment for adults with thyroid eye disease (TED). This humanized monoclonal antibody targets interleukin (IL)-6 receptors, inhibiting IL-6-mediated signaling.

Data from the phase III SatraGO-1 and SatraGO-2 studies, involving 258 patients across 19 countries, demonstrated a reduction in proptosis and diplopia in the satralizumab group compared to placebo. Results were consistent across the trial population, including patients with active and chronic TED.

Sponsored content

The availability of this subcutaneous option offers greater flexibility for patients and physicians. Satralizumab’s safety profile is consistent with its profile for neuromyelitis optica spectrum disorder. Common adverse events included upper respiratory tract infections and increased alanine aminotransferase levels. Contraindications include active or untreated latent tuberculosis and active hepatitis B infection. Screening for hepatitis B, tuberculosis, and liver transaminase is required before treatment. The drug is administered via subcutaneous injection, initially at weeks 0, 2, and 4, followed by maintenance injections every 4 weeks. Additional studies are ongoing for other neurologic, autoimmune, and inflammatory diseases.

Original Scientific Source
medical-news
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement